Solara Active Pharma Sciences Ltd.

436.80 -22.75 ▼-5.0%

28 February 2024, 04:01:00 PM
Volume: 35,983

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.solara.co.in
Market Cap 1,572.32 Cr.
Enterprise Value(EV) 2,620.69 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -85.64 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.82 Trailing Twelve Months Ending 2023-12
Book Value / Share 330.06 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.32 Calculated using Price: 436.80
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 3.60 Cr. 35,996,267 Shares
FaceValue 10
About Solara Active Pharma Sciences Ltd.
Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer. It has a legacy of over three decades and trace its origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. The company is a global, R&D focused, pureplay API company engaged in the manufacturing and development of APIs and offering Contract Manufacturing and Development Services for global companies.

Solara Active Pharma Sciences Ltd. Delivery

Delivered Qty
Traded Qty

Solara Active Pharma Sciences Ltd. Performance

1 Day
-4.95%
1 Week
-5.90%
1 Month
+12.27%
3 Month
+30.04%
6 Month
+19.69%
1 Year
+21.32%
2 Year
-36.23%
5 Year
+17.67%
10 Year

Solara Active Pharma Sciences Ltd. Fundamental Ratios

6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0.78 8.32 12.48 17.23 -3.75 -1.47
Return on Capital Employed (%) 2.22 10.38 11.73 15.34 -0.67 1.79
Return on Assets (%) 0.33 3.55 5.57 9.34 -2.13 -0.78

Solara Active Pharma Sciences Ltd. Balance Sheet

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 764 956 1,086 1,589 1,525 1,500 1,463
Non Curr. Liab. 315 344 333 206 299 217 155
Curr. Liab. 738 656 730 789 1,063 1,101 1,165
Minority Int. 4 4 4 4 2 2 3
Equity & Liab. 1,821 1,960 2,153 2,588 2,890 2,821 2,787
Non Curr. Assets 1,214 1,312 1,481 1,530 1,651 1,633 1,592
Curr. Assets 608 648 672 1,058 1,239 1,188 1,195
Misc. Exp. not W/O
Total Assets 1,821 1,960 2,153 2,588 2,890 2,821 2,787

Solara Active Pharma Sciences Ltd. Profit and Loss

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 521 1,387 1,322 1,617 1,268 1,444 1,407
Other Income 2 12 28 29 20 23 8
Total Income 523 1,399 1,349 1,646 1,288 1,466 1,415
Total Expenditure -458 -1,166 -1,062 -1,231 -1,188 -1,310 -1,463
PBIDT 65 233 287 415 100 156 -48
Interest -25 -82 -78 -84 -75 -90 -96
Depreciation -34 -83 -94 -109 -112 -111 -105
Taxation 0 -1 0 0 33 23 9
Exceptional Items -3 -68
PAT 6 67 115 221 -58 -22 -308
Minority Interest 0 0 0 0 0 0 -1
Share Associate
Other Related Items
Consolidated Net Profit 0 60 115 221 -58 -22 -308
Adjusted EPS 0 23 43 62 -16 -6 -86

Solara Active Pharma Sciences Ltd. Cash Flow

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 49 166 242 155 -242 156
Cash Fr. Inv. -85 -116 -359 -106 -243 -81
Cash Fr. Finan. 68 -23 97 92 334 -113
Net Change 31 27 -20 142 -151 -38
Cash & Cash Eqvt 46 76 56 198 46 9

Solara Active Pharma Sciences Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 39.51 39.71 40.40 40.40 40.40 40.97 39.31 37.19 30.49
Public 60.49 60.29 59.60 59.60 59.60 59.03 60.69 62.81 69.51
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 29.44 27.51 27.98 28.18 33.73 40.46 39.79 43.47 49.06

Solara Active Pharma Sciences Ltd. Announcements

Mon, 26 Feb 2024
Change In Senior Management Personnel
Change in Senior Management Personnel
Wed, 21 Feb 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings conference call for the quarter ended December 31 2023.
Thu, 15 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith copies of newspaper publication.

Solara Active Pharma Sciences Ltd. Technical Scans

Tue, 27 Feb 2024
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Month High Close Above Last Month High
Closing Below Previous Low for 2 Days Closing Below Previous Low for 2 Days
Making Lower Lows for 2 Days Making Lower Lows for 2 Days

Solara Active Pharma Sciences Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 379,622.78 1,570.50 -0.7%
Cipla Ltd. 120,180.38 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. 107,577.80 6,420.70 -0.4%
Zydus Lifesciences Ltd. 95,400.24 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. 95,163.88 6,371.85 -3.7%
Divi's Laboratories Ltd. 93,921.46 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. 88,823.31 2,598.00 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.62 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 32.41 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.58 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 120.56 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-12 67.91 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.45 2,598.00 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.08 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 4.64 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.09 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-12 7.21 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.42 2,598.00 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,598.00 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,598.00 -1.0%

Solara Active Pharma Sciences Ltd. FAQ's

What is Solara Active Pharma share price?

Can I buy Solara Active Pharma shares now?

What is the Market Cap of Solara Active Pharma?

What are the key metrics to analyse Solara Active Pharma?

What is the 52 Week High and Low of Solara Active Pharma?

What is the trend of Solara Active Pharma share price?